Alicia Moreno Gonzalez

Alicia Moreno Gonzalez has a diverse work experience in the field of clinical science and technology development. Alicia currently holds the position of Senior Principal Clinical Scientist at Galvanize Therapeutics, Inc. Alicia joined the company in January 2021.

Prior to their current role, Alicia worked at Philips from April 2017 to January 2021 as a Senior Clinical Development Scientist. In this role, they were responsible for clinical study designs and accurate reporting of clinical data. Alicia ensured that the clinical studies were conducted in compliance with regulatory standards and developed and maintained Clinical Evaluation Plans and Reports.

Before joining Philips, Alicia worked at Presage Biosciences, Inc. from 2011 to 2017 as the Director of Clinical Technology Development. Alicia led technology development projects and managed a multidisciplinary team to design, develop, and manufacture devices for human studies. Alicia also played a key role in device regulatory strategy and managed regulatory projects.

Alicia began their career at the University of Washington, where they worked as a Senior Fellow from 2009 to 2010. In this role, they developed novel techniques for engineering monocytes and coordinated a molecular biology team for vector constructs. Alicia also presented project findings to technical and general audiences.

Prior to their role at the University of Washington, Alicia worked at CellCyte Genetics Corp (CCYG) as a Scientist from 2007 to 2008. Alicia'sresponsibilities included developing animal models and protocols, training research associates, and managing research study projects.

Alicia's earlier experience includes working as a Research Assistant at the University of Washington from 2001 to 2007. In this role, they engineered mechanical instrumentation systems, managed collaborations between laboratory groups, and supervised undergraduate research projects.

Overall, Alicia Moreno Gonzalez has a strong background in clinical science, technology development, and research, with experience in leading teams and managing regulatory projects.

Alicia Moreno Gonzalez completed their education in the field of Bioengineering, starting in 2001 and ending in 2007, at the University of Washington, where they obtained a Ph.D. degree. In 2014 to 2015, they pursued further education in Biomedical Regulatory Affairs, earning a certificate from the University of Washington. In 2010, they obtained a certificate in Biotechnology Project Management from the same institution. Prior to their studies at the University of Washington, Alicia completed a Bachelor of Science degree in Physics Engineering from Tecnológico de Monterrey, spanning from 1995 to 1999.